Access to anti-retroviral drugs, female in Ghana

Ghana: Access to anti-retroviral drugs, female was 51.0% in 2024. ◆ Volatile

Latest (2024)
51.0%
Change on year
up 2.0%
World rank
118th
of 141 countries
All-time high
51.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Ghana, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 1 %2005: 1 %2006: 2 %2007: 4 %2008: 7 %2009: 10 %2010: 13 %2011: 20 %2012: 24 %2013: 26 %2014: 29 %2015: 33 %2016: 36 %2017: 38 %2018: 39 %2019: 40 %2020: 43 %2021: 46 %2022: 50 %2023: 50 %2024: 51 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Ghana is 51.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 2.0% on the previous year and up 75.9% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Ghana peaked at 51.0% in 2024 and was at its lowest, 0.0%, in 2000.

Ghana ranks 118th of 141 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Ghana, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Ghana, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 1.0% +0.0%
2006 2.0% +100.0%
2007 4.0% +100.0%
2008 7.0% +75.0%
2009 10.0% +42.9%
2010 13.0% +30.0%
2011 20.0% +53.8%
2012 24.0% +20.0%
2013 26.0% +8.3%
2014 29.0% +11.5%
2015 33.0% +13.8%
2016 36.0% +9.1%
2017 38.0% +5.6%
2018 39.0% +2.6%
2019 40.0% +2.6%
2020 43.0% +7.5%
2021 46.0% +7.0%
2022 50.0% +8.7%
2023 50.0% +0.0%
2024 51.0% +2.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 2.5% 0.0% 10.0% 10
2010s 29.8% 13.0% 40.0% 10
2020s 48.0% 43.0% 51.0% 5

Countries ranked near Ghana

  1. 116 Armenia 52.0% compare
  2. 116 Libya 52.0% compare
  3. 118 Belize 51.0% compare
  4. 118 Papua New Guinea 51.0% compare
  5. 118 South Sudan 51.0% compare

See the full ranking of 160 places →

More gender data for Ghana

All data for Ghana →

Frequently asked questions

What is access to anti-retroviral drugs, female in Ghana?
Access to anti-retroviral drugs, female in Ghana was 51.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Ghana?
The highest recorded value was 51.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Ghana?
The lowest recorded value was 0.0% in 2000.
How does Ghana rank for access to anti-retroviral drugs, female?
Ghana ranks 118th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Ghana?
Over the last ten years it is up 75.9%. The long-run trend across the full record is volatile.
Where does this Ghana data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Ghana. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/ghana/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/ghana/">Access to anti-retroviral drugs, female in Ghana</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.